Matters of legal in nature including licensing, intellectual property, and lawsuits.
16 Nov 2017 Print this page Smiths Detection IONSCAN 600 First ‘Approved’ Explosives Trace Detector on New TSA Air Cargo Screening List Edgewood, MD – Smiths Detection’s IONSCAN 600 is the first explosives trace detection system to be ‘Approved’ on the TSA Air Cargo Screening Technology List (ACSTL) under the latest program requirements to ensure... Read more
Download PDF November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist... Read more
November 16, 2017 8:12 A.M. Eastern Time RESEARCH TRIANGLE PARK, DURHAM, NC—(BUSINESS WIRE)—Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the European Patent Office has issued EPO Patent Nos. 1581612 and 2719756 covering the design of Xona’s products used for neuroscientific and... Read more
AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017. The presentation will be webcast live... Read more
AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017. The presentation will be webcast live... Read more
Download PDF Read more
DUBLIN, Ireland, and Mountain View, CA, November 10, 2017 – ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, who... Read more
Basel, 10 November 2017 Roche’s OCREVUS (ocrelizumab) gains positive CHMP opinion for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis If approved, OCREVUS will be an important treatment option for people with active relapsing forms of multiple sclerosis (RMS) showing superior efficacy on three major markers of disease activity and disability progression compared... Read more
Technology originally developed for Department of Defense field applications REDMOND, Wash., Nov. 9, 2017 /PRNewswire/ — Photonic BioSystems (www.photonicbiosystems.com) announces that they are actively seeking commercialization partners (licensees) to bring their Rapid Microbial Detection and Sampling technologies to market. The technologies enable rapid sampling, detection and measurement of bacteria, cells, microorganisms and microbial contaminants – including E. coli,... Read more